HomeEVLO • OTCMKTS
add
Evelo Biosciences Inc
Previous close
$0.00
Day range
$0.00010 - $0.00010
Market cap
1.89K USD
Avg Volume
613.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 108.47M | -6.01% |
Net income | -114.53M | 6.26% |
Net profit margin | — | — |
Earnings per share | -22.68 | 43.57% |
EBITDA | -106.41M | 5.99% |
Effective tax rate | -0.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.94M | -29.95% |
Total assets | 64.44M | -26.66% |
Total liabilities | 69.43M | -12.34% |
Total equity | -4.99M | — |
Shares outstanding | 5.55M | — |
Price to book | -0.00 | — |
Return on assets | -89.02% | — |
Return on capital | -122.03% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -114.53M | 6.26% |
Cash from operations | -101.24M | -4.66% |
Cash from investing | -622.00K | 58.00% |
Cash from financing | 81.66M | -16.29% |
Net change in cash | -20.66M | -3,001.50% |
Free cash flow | -61.02M | 0.14% |
About
Founded
2014
Website
Employees
66
